Neurological status was studied in 50 jaundiced infants with a total serum bilirubln of >400/tmol/l (23.4 mg/dl). Infants were assessed in the neonatal period with the Neonatal Neurological Examination and at 4 months of age with the Infant Motor Screen. Twenty-six (52 per cent) infants were premature. Analysis of variance did not show a significant difference between gestational age, birth weight, and maximum total serum bilirubin or between gestational age, birth weight, and neurological optimality score. Based on the presence of abnormal neurological syndromes the infants were classified as normal (n = 27), suspect (n = 11), or abnormal (n = 12). Serum bilirubin levels were higher (p < 0.0001) and the neonatal neurological examination scores lower (p < 0.001) in the seven (14 per cent) infants who received an exchange transfusion. In the transfused group four out of seven infants and in the non-transfused group seven out of 43 infants were classified as abnormal (p < 0.03).
Introduction
Half a century ago acute bilirubin encephalopathy, or kernicterus, was a frequently occurring neonatal syndrome in industrialized countries. It was associated with a high serum bilirubin concentration in infants with severe haemolytic disease.' Following the introduction of exchange transfusions in the early 1950s, kernicterus became rare in Europe and the USA. In developing countries, however, severe jaundice is still a major health problem. In Nigeria 50 percent of the children attending neurology outpatient clinics had bilirubin-related cerebral palsy. 2 
"
3 In Zimbabwe, 14 per cent of the newly registered cerebral palsy children at Mpilo Central Hospital, Bulawayo and 12.8 per cent of the 1107 registered cases at the Children's Rehabilitation Unit in Harare were related to bilirubin encephalopathy. 4 However, prospective follow-up data on severely jaundiced infants is lacking.
The aims of the study were (a) to investigate the neonatal neurological status of severely jaundiced Zimbabwean neonates and (b) to establish the sensitivity and specificity of the Neonatal Neurological Examination.
Patients and Methods
Between 1st July 1991 and 30th June 1992, 50 jaundiced infants admitted to the Special Baby Care Unit (SBCU) in Mpilo Central Hospital, Bulawayo, with a maximum total serum bilirubin (TSB) of >400/*mol/l (23.4 mg/dl), were examined with the Neonatal Neurological Examination (NNE) adapted from Prechtl. 5 Lack of staff meant that only infants with a very high TSB level could be assessed. TSB was determined with direct spectrophotometry. In addition, the blood group of the mother and child was defined. Infants were screened for congenital syphilis and blood was cultured when sepsis was suspected. Infants with hyperbilirubinaemia were always treated with phototherapy. Due to a severe shortage of skilled staff at that time only a few infants received an exchange transfusion.
Examination of the infants took place at least three days after birth when they were in a stable condition. Preterm infants, diagnosed according to the Dubowitz M J. WOLFETAL. score, were examined when they had reached term gestational age. The adapted NNE consists of 84 items (test available on request). For each item of the test an optimal range was defined resulting in a neurological optimality score, the sum score, with a maximum of 84. Based on the classification as proposed by Jurgens-van der Zee 7 an infant was considered neurologically abnormal if one or more of the following syndromes were present: hyperexcitability syndrome, apathy syndrome, severe hypertonia, severe hypotonia, central or peripheral asymmetry. An infant was considered suspect if only symptoms of a syndrome were present, such as mild hypotonia or slight tremors only. Infants returned for a follow-up at 4 months corrected for gestational age and a neurodevelopmental examination with the Infant Motor Screen (IMS) according to Nickel was administered. The IMS was chosen because it has been found to be a useful neurological evaluation technique for the identification of infants with a subsequent diagnosis of cerebral palsy in a population of high-risk infants. 8 Fourteen items are tested at 4 months of age. Each test item scores on a three point scale. Scores between 0 and 9 are rated as normal, between 10 and 14 as suspect, and 15 or above as abnormal.
The performance of infants who were normal, suspect, and abnormal on the NNE was compared with their IMS performance at 4 months using the Spearman p coefficient. Sensitivity, specificity, positive predictive value, and negative predictive value of the NNE were calculated, first excluding the suspect infants and then including the suspect infants in the abnormal category. Chi-squared tests, Pearson product-moment correlation, and analysis of variance (ANOVA) were used to analyse the data. An alpha coefficient of 0.05 was selected as the level of significance.
Results
The total number of deliveries at the hospital during the study period was 10508, of which 3753 (36 per cent) infants were admitted to the SBCU. Fifty infants developed severe jaundice in the first week of life; 46 of them (20 term and 26 preterm infants) while in the SBCU. Four term infants had been readmitted within 5 days of birth. All infants had an Apgar score of >6 at 5 min. None of the infants was ventilated. Twentysix (52 per cent) infants were premature and six (12 per cent) were small for gestational age. The cause of jaundice was low birth weight in 22, ABO incompatibility in eight, sepsis in eight, and congenital syphilis in three infants. In nine infants the cause could not be determined. Only seven (one preterm, six term) infants (14 per cent) received an exchange blood transfusion.
The mean value for weight, gestational age, head circumference, maximum total serum bilirubin, and neurological status for the transfused and non-transfused babies are presented in Table 1 . Serum bilirubin levels were higher (p< 0.0001) and sum scores lower (p < 0.001) in the transfused infants. The four readmitted infants already showed signs of bilirubin encephalopathy before the exchange transfusion was carried out. Analysis of variance did not show a significant difference between gestational age, birth weight, and maximum TSB or between gestational age, birth weight and sum score (Tables 2 and 3 ).
The neonatal neurological classification was not related to the TSB levels (Table 4) . Based on the presence of abnormal neurological syndromes the infants were classified as normal (n = 27), suspect (n = 11), or abnormal (n = 12). The sum score of the infants who were classified as normal was significantly higher than that of infants who were suspect or abnormal (p< 0.0001). Four of the seven (57 per cent) infants who received an exchange transfusion and seven of the 43 (16 per cent) non-transfused infants were classified as abnormal (p < 0.03).
At 4 months, two infants had died and three were lost to follow-up, leaving 45 infants to be evaluated using the IMS. On the IMS six of the 45 (13.3 per cent) infants scored as abnormal, six (13.3 per cent) as suspect, and 33 (73 per cent) scored as normal. There was a significant linear correlation between the NNE score and IMS test result (r = -0.59, p < 0.001). The NNE proved to be sensitive to developmental abnormality in the neonatal period and correctly identified five of the six (83 per cent) infants who were classified as abnormal at 4 months. With the suspect infants excluded the specificity of the NNE was 88 per cent and the positive and negative predictive values were 62.5 and 96 per cent, respectively. However, when the suspect infants were included in the abnormal category of the NNE, both the sensitivity and the negative predictive value remained the same, but the specificity and positive predictive value decreased to 67 and 31 per cent, respectively. Discussion As a result of interventions directed at controlling hyperbilirubinaemia, acute bilirubin encephalopathy has virtually disappeared in industrialized countries.
Bilirubin encephalopathy, however, is still a major health problem in Africa, with high morbidity rates.
2 -'' Birth weight in our study population was significantly lower than in infants with hyperbilirubinaemia from industrialized countries 12 and 64 per cent had a birth weight of less than 2500 g. Our findings support the study of Madan and Sood 13 who found that low birth weight was a contributing factor in neonates with severe hyperbilirubinaenia in Nigeria. Out of the seven transfused infants in our study, four (57 per cent) infants were classified as abnormal. Serum bilirubin levels, however, were higher in the transfused infants and four of these infants already showed signs of encephalopathy before an exchange transfusion could be carried out. Van de Bor found more neurological impairments in children at 2 years of age who were transfused in the neonatal period than in infants who had not received exchange transfusions. 14 We found a strong correlation between the NNE and the IMS. The purpose of the NNE is to identify infants who require follow-up. It is important, therefore, that the sensitivity of the neonatal test is high, so that potentially abnormal infants are not missed. The specificity of 88 per cent, however, decreased to 67 per cent when the suspect infants of the neonatal period were included in the abnormal category of the NNE. A significant number of infants who were abnormal or suspect in the neonatal period were tested as being normal on the IMS at 4 months. This high number of false positives in the NNE may be a reflection of the poor clinical condition of infants bom with severe hyperbilirubinaemia. The majority of the high-risk infants who had normal NNE results were shown to have remained normal at 4 months of age. This is reassuring and avoids unnecessary followup, especially in developing countries where resources are scarce.
In conclusion, the NNE adapted from PrechtJ is an effective screening test for the early identification of neurodevelopmental abnormality in severely jaundiced babies in Africa; further follow-up is needed to confirm this.
